Search by Drug Name or NDC
NDC 61958-2902-02 Veklury 5 mg/mL Details
Veklury 5 mg/mL
Veklury is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Gilead Sciences, Inc.. The primary component is REMDESIVIR.
MedlinePlus Drug Summary
Remdesivir injection is used to treat coronavirus disease 2019 (COVID-19 infection) caused by the SARS-CoV-2 virus in hospitalized adults and children 28 days of age and older who weigh at least 6.6 pounds (3 kg). Remdesivir injection is also used to treat coronavirus disease 2019 (COVID-19 infection) caused by the SARS-CoV-2 virus in non-hospitalized adults and children 28 days of age and older who weigh at least 6.6 pounds (3 kg) who are at high risk of progression to severe COVID-19, including hospitalization and death. Remdesivir is in a class of medications called antivirals. It works by stopping the virus from spreading in the body.
Related Packages: 61958-2902-02Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Remdesivir Injection
Product Information
| NDC | 61958-2902 |
|---|---|
| Product ID | 61958-2902_719b5296-b090-4720-98ce-00cee723fd91 |
| Associated GPIs | 12700080002020 |
| GCN Sequence Number | 081036 |
| GCN Sequence Number Description | remdesivir VIAL 100MG/20ML INTRAVEN |
| HIC3 | W0L |
| HIC3 Description | ANTIVIRAL - RNA POLYMERASE INHIBITOR |
| GCN | 48037 |
| HICL Sequence Number | 046410 |
| HICL Sequence Number Description | REMDESIVIR |
| Brand/Generic | Generic |
| Proprietary Name | Veklury |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | remdesivir |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/mL |
| Substance Name | REMDESIVIR |
| Labeler Name | Gilead Sciences, Inc. |
| Pharmaceutical Class | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA214787 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 61958-2902-02 (61958290202)
| NDC Package Code | 61958-2902-2 |
|---|---|
| Billing NDC | 61958290202 |
| Package | 1 VIAL, SINGLE-DOSE in 1 CARTON (61958-2902-2) / 20 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2022-03-25 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |